Loading…
Artivion, Inc. is projected to rise to $30.00 by 2027, a +12% move from its current price of $26.83. AORT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $26.21 | $26.84 | $27.48 | +0.03% |
| Aug 3 | $25.96 | $26.85 | $27.76 | +0.06% |
| Aug 4 | $25.77 | $26.85 | $27.98 | +0.09% |
| Aug 5 | $25.61 | $26.86 | $28.17 | +0.12% |
| Aug 6 | $25.48 | $26.87 | $28.34 | +0.15% |
| Aug 7 | $25.36 | $26.88 | $28.49 | +0.17% |
| Aug 8 | $25.25 | $26.88 | $28.63 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $25.25 | $26.88 | $28.63 | +0.20% |
| Week 2 | $24.65 | $26.94 | $29.45 | +0.41% |
| Week 3 | $24.21 | $26.99 | $30.10 | +0.61% |
| Week 4 | $23.85 | $27.05 | $30.68 | +0.82% |
| Week 5 | $23.55 | $27.10 | $31.20 | +1.02% |
| Week 6 | $23.28 | $27.16 | $31.68 | +1.23% |
| Week 7 | $23.04 | $27.21 | $32.14 | +1.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. Its product portfolio includes On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system.
The company markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia. It was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022.
The stock trades under the ticker AORT and has a current price of $27.55. It operates in the healthcare sector.
Its market capitalization sits at $1.34B, and it ranks 2329 by market cap. This provides context for its size within the market.
The forecast maps a rising price path from 2026 onward, with 2026 avg at $27.55 and 2050 avg at $218.49. Notable intermediate milestones include 2029 avg $39.42 and 2030 avg $45.98.
The outlook indicates a bullish tilt in the later years with ROI expanding to 693% by 2050. In the near term, 2026 shows neutral expectations.
A major floor 35.4% below — a decisive break under it would weaken the trend.
The nearest floor, 25.0% below — buyers have tended to step in here.
The nearest ceiling, 3.1% above — a clean break opens room to run.
A major ceiling 44.6% above — clearing it would confirm fresh momentum.
Key AORT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AORT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.03 | Sell | $26.86 | Sell |
| MA 10 | $26.09 | Buy | $26.26 | Buy |
| MA 20 | $25.20 | Buy | $25.36 | Buy |
| MA 50 | $23.09 | Buy | $25.35 | Buy |
| MA 100 | $28.65 | Sell | $28.20 | Sell |
| MA 200 | $35.88 | Sell | $31.57 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.92 | Neutral |
| Stoch RSI (14) | 64.67 | Neutral |
| CCI (20) | 109.37 | Buy |
| Williams %R (14) | -18.50 | Info |
| MACD (12,26,9) | 0.25 | Buy |
| ROC (12) | 10.37 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 81.50 | Sell |
| TRIX (15) | 0.51 | Buy |
| Awesome (5,34) | 3.19 | Buy |
| Ultimate (7,14,28) | 70.54 | Sell |
| Momentum (10) | 1.77 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 27.92 | Sell |
| ADX (14) | 21.65 | Buy |
| ATR (14) | 0.58 | Info |
The 30-day technical picture is bullish. Momentum indicators align with an uptrend.
RSI14 is 70, and the 50-day and 200-day simple moving averages stand at $22.93 and $36.01 respectively. The stock has a support level at $20.13 and a resistance at $27.55.
The 30-day price range runs from $23.46 to $32.35, highlighting near-term volatility within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $20.10 | $26.83 | $34.79 | 0% | Neutral | |
| $24.21 | $30.00 | $39.13 | +12% | Neutral | |
| $25.23 | $32.03 | $43.20 | +19% | Neutral | |
| $29.47 | $38.17 | $52.83 | +42% | Bullish | |
| $33.81 | $44.57 | $63.06 | +66% | Bullish | |
| $37.85 | $50.70 | $73.12 | +89% | Bullish | |
| $40.03 | $54.42 | $79.83 | +103% | Bullish | |
| $39.60 | $54.58 | $81.33 | +103% | Bullish | |
| $41.56 | $58.03 | $87.72 | +116% | Bullish | |
| $46.04 | $65.09 | $99.71 | +143% | Bullish | |
| $63.01 | $94.23 | $152.66 | +251% | Bullish | |
| $127.75 | $210.12 | $369.57 | +683% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $20.10 | $26.83 | $32.49 | +0.00% |
| September 2026 | $23.62 | $27.84 | $33.67 | +3.75% |
| October 2026 | $23.24 | $27.55 | $33.63 | -1.03% |
| November 2026 | $22.90 | $27.28 | $33.55 | -0.98% |
| December 2026 | $23.48 | $28.09 | $34.79 | +2.99% |
Click any year to see its month-by-month AORT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The AORT price prediction for 2026 points to an average of $26.83 (low $20.10, high $34.79) — a potential gain of 0% on today's $26.83. A consolidation phase looks the most probable path here.
In 2027, AORT is projected to trade between $24.21 and $39.13, averaging $30.00 — a potential gain of +12% from today's $26.83. That is up +12% on the projected 2026 average. Price action looks broadly range-bound.
Artivion, Inc.'s 2028 outlook centres on $32.03, within a $25.23 to $43.20 range. That is up +7% on the projected 2027 average. That marks a +19% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, AORT could reach as high as $52.83, with a base case around $38.17 and support toward $29.47 — roughly +42% from $26.83. Momentum favours further upside here.
Expect AORT to range from $33.81 to $63.06 through 2030. The $44.57 average target implies a +66% move from current prices. That is up +17% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The AORT price prediction for 2031 points to an average of $50.70 (low $37.85, high $73.12) — a potential gain of +89% on today's $26.83. Momentum favours further upside here.
In 2032, AORT is projected to trade between $40.03 and $79.83, averaging $54.42 — a potential gain of +103% from today's $26.83. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Artivion, Inc.'s 2033 outlook centres on $54.58, within a $39.60 to $81.33 range. That is up 0% on the projected 2032 average. That marks a +103% change versus current levels. Momentum favours further upside here.
By 2034, AORT could reach as high as $87.72, with a base case around $58.03 and support toward $41.56 — roughly +116% from $26.83. Buyers look set to stay in control over this stretch.
Expect AORT to range from $46.04 to $99.71 through 2035. The $65.09 average target implies a +143% move from current prices. That is up +12% on the projected 2034 average. Momentum favours further upside here.
The AORT price prediction for 2040 points to an average of $94.23 (low $63.01, high $152.66) — a potential gain of +251% on today's $26.83. Buyers look set to stay in control over this stretch.
In 2050, AORT is projected to trade between $127.75 and $369.57, averaging $210.12 — a potential gain of +683% from today's $26.83. That is up +123% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in AORT today (≈ 37.271711 AORT) could be worth
$7,831.39
+$6,831.39 (+683%) by 2050 · US Dollar
Based on the average projected AORT price of $210.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AORTwould be worth at today's price.
$1,000 invested in AORT on Jul 31, 2025 (≈ 32.35199 AORT) would be worth
$868
-$132 (-13.2%) today · 0.87× · US Dollar
Based on a AORT entry price of $30.91 vs. today's $26.83.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.28 | $1,061.31 | +6.1% |
| 1 month ago | $23.55 | $1,139.28 | +13.9% |
| 3 months ago | $36.21 | $740.96 | -25.9% |
| 6 months ago | $41.23 | $650.74 | -34.9% |
| 1 year ago | $30.91 | $868 | -13.2% |
| All time (5.0y) ago | $26.95 | $995.55 | -0.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AORT forecast.
Our base-case forecast reaches $54.00 around 2032.
Implied market cap at $54.00: $2.62B
The multi-year forecast portrays a pronounced uptrend, with the average price rising from $39.42 in 2029 to $218.49 by 2050. Notable mid-term milestones include 2030 with an average of $45.98 and 2040 with an average of $97.40.
Forecasted ROI progresses from 43.1% in 2029 to 66.9% in 2030, then to 253.5% in 2040 and 693% in 2050.
Sentiment is NEUTRAL for 2026, 2027, and 2028 and turns BULLISH from 2029 onward. These figures are estimates and not guarantees, and actual results depend on market dynamics and company performance.
Tap a question to reveal the answer.
Avg $45.98; min $34.75; max $65.35; ROI 66.9; sentiment BULLISH.
Forecasts show bullish sentiment from 2029 onward, with 2029 avg $39.42, 2030 avg $45.98, 2040 avg $97.40, and 2050 avg $218.49; ROI reaches 693% by 2050.
Yes. The forecast max prices reach $103.97 by 2035, $158.93 by 2040, and $387.54 by 2050.
Current price $27.55; market cap $1.34B.
30-day range low $23.46; high $32.35.
Artivion, Inc. Community Discussion
0Share your Artivion, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.